CN101657535B - 源于大鼠及其它动物的多潜能细胞 - Google Patents

源于大鼠及其它动物的多潜能细胞 Download PDF

Info

Publication number
CN101657535B
CN101657535B CN200780036720.1A CN200780036720A CN101657535B CN 101657535 B CN101657535 B CN 101657535B CN 200780036720 A CN200780036720 A CN 200780036720A CN 101657535 B CN101657535 B CN 101657535B
Authority
CN
China
Prior art keywords
cells
rat
medium
cell
pluripotent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN200780036720.1A
Other languages
English (en)
Chinese (zh)
Other versions
CN101657535A (zh
Inventor
应其龙
A·G·史密斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Edinburgh
Original Assignee
University of Edinburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Edinburgh filed Critical University of Edinburgh
Publication of CN101657535A publication Critical patent/CN101657535A/zh
Application granted granted Critical
Publication of CN101657535B publication Critical patent/CN101657535B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0273—Cloned vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/101—Bovine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/103—Ovine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/108—Swine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/235—Leukemia inhibitory factor [LIF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Environmental Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Reproductive Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CN200780036720.1A 2006-08-01 2007-08-01 源于大鼠及其它动物的多潜能细胞 Expired - Fee Related CN101657535B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB0615327.4A GB0615327D0 (en) 2006-03-30 2006-08-01 Culture medium containing kinase inhibitors and uses thereof
GB0615327.4 2006-08-01
GBGB0700479.9A GB0700479D0 (en) 2006-08-01 2007-01-10 Culture medium containing kinase inhibitors, and uses thereof
GB0700479.9 2007-01-10
PCT/GB2007/002913 WO2008015418A2 (en) 2006-08-01 2007-08-01 Pluripotent cells from rat and other species

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201410720584.XA Division CN104531610A (zh) 2006-08-01 2007-08-01 源于大鼠及其它动物的多潜能细胞

Publications (2)

Publication Number Publication Date
CN101657535A CN101657535A (zh) 2010-02-24
CN101657535B true CN101657535B (zh) 2016-03-02

Family

ID=37809760

Family Applications (2)

Application Number Title Priority Date Filing Date
CN200780036720.1A Expired - Fee Related CN101657535B (zh) 2006-08-01 2007-08-01 源于大鼠及其它动物的多潜能细胞
CN201410720584.XA Pending CN104531610A (zh) 2006-08-01 2007-08-01 源于大鼠及其它动物的多潜能细胞

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201410720584.XA Pending CN104531610A (zh) 2006-08-01 2007-08-01 源于大鼠及其它动物的多潜能细胞

Country Status (7)

Country Link
US (2) US8431395B2 (cg-RX-API-DMAC7.html)
EP (1) EP2049654A2 (cg-RX-API-DMAC7.html)
JP (2) JP5456467B2 (cg-RX-API-DMAC7.html)
CN (2) CN101657535B (cg-RX-API-DMAC7.html)
AU (1) AU2007280216B2 (cg-RX-API-DMAC7.html)
GB (3) GB0615327D0 (cg-RX-API-DMAC7.html)
WO (1) WO2008015418A2 (cg-RX-API-DMAC7.html)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7682828B2 (en) 2003-11-26 2010-03-23 Whitehead Institute For Biomedical Research Methods for reprogramming somatic cells
US8357666B2 (en) * 2005-08-01 2013-01-22 Nupotential, Inc. Reprogramming a cell by inducing a pluripotent gene through RNA interference
EP1999249B8 (en) * 2006-03-30 2012-02-15 The University Court Of The University of Edinburgh Culture medium containing kinase inhibitors. and uses thereof
MX352541B (es) 2007-04-07 2017-11-29 Whitehead Inst Biomedical Res Reprogramación de células somáticas.
US9080145B2 (en) 2007-07-01 2015-07-14 Lifescan Corporation Single pluripotent stem cell culture
CN101918541A (zh) * 2007-07-18 2010-12-15 塞拉提斯股份公司 衍生自hBS细胞的心肌细胞样细胞簇
CA2695225C (en) 2007-07-31 2021-06-01 Lifescan, Inc. Differentiation of human embryonic stem cells to pancreatic endocrine
WO2009032194A1 (en) 2007-08-31 2009-03-12 Whitehead Institute For Biomedical Research Wnt pathway stimulation in reprogramming somatic cells
CA2718904C (en) 2008-03-17 2017-01-03 The Scripps Research Institute Combined chemical and genetic approaches for generation of induced pluripotent stem cells
AU2009233845A1 (en) * 2008-04-07 2009-10-15 Nupotential, Inc. Reprogramming a cell by inducing a pluripotent gene through use of a small molecule modulator
CA2969377C (en) 2008-06-13 2019-12-03 Whitehead Institute For Biomedical Research Programming and reprogramming of cells
EP2942392B1 (en) 2008-06-30 2018-10-03 Janssen Biotech, Inc. Differentiation of pluripotent stem cells
EP2369916A4 (en) * 2008-12-01 2013-04-10 Univ Texas PREPARATION AND USE OF SPERMATOGONIAL STEM CELL LINES FROM THE RAT
ES2645869T3 (es) 2008-12-17 2017-12-11 The Scripps Research Institute Generación y mantenimiento de células madre
EP2421956A4 (en) * 2009-04-24 2013-10-02 Whitehead Biomedical Inst COMPOSITIONS AND METHODS FOR OBTAINING OR CULTURING PLURIPOTENTER CELLS
JP5808331B2 (ja) * 2009-10-16 2015-11-10 ザ スクリプス リサーチ インスティテュート 多能性細胞の誘導法
EP2508595B1 (en) 2009-12-01 2016-11-23 National Cancer Center Method for constructing chimeric rat using rat embryonic stem cells
EP2505639B1 (en) * 2009-12-29 2018-09-19 Takeda Pharmaceutical Company Limited Method for manufacturing pancreatic-hormone-producing cells
ES2624780T3 (es) 2010-03-31 2017-07-17 The Scripps Research Institute Reprogramación de células
US20130059375A1 (en) * 2010-04-02 2013-03-07 Riken Method for preparing es cells
ES2685171T3 (es) 2010-06-14 2018-10-05 The Scripps Research Institute Reprogramación de células a un nuevo destino
CN102344490B (zh) * 2010-07-30 2014-03-05 中国科学院上海生命科学研究院 抗小鼠Stk40的多克隆抗体及其制备
NZ607608A (en) * 2010-08-09 2014-03-28 Takeda Pharmaceuticals Co Method of producing pancreatic hormone-producing cells
JP6090855B2 (ja) * 2010-11-17 2017-03-08 国立大学法人京都大学 心筋細胞および／または心筋前駆細胞増殖剤ならびに心筋細胞および／または心筋前駆細胞の増殖方法
KR101975688B1 (ko) 2010-12-22 2019-05-07 페이트 세러퓨틱스, 인코포레이티드 단세포 분류 및 iPSC의 증강된 재프로그래밍을 위한 세포 배양 플랫폼
US20140127133A1 (en) * 2011-01-24 2014-05-08 Claude Brodski Method for evaluating a mental disorder
US20140234963A1 (en) 2011-06-21 2014-08-21 Novo Nordisk A/S Efficient induction of definitive endoderm from pluripotent stem cells
SI3865581T1 (sl) 2011-08-05 2024-12-31 Regeneron Pharmaceuticals, Inc. Miši s humanizirano univerzalno lahko verigo
PL2793567T3 (pl) * 2011-12-20 2019-09-30 Regeneron Pharmaceuticals, Inc. Myszy z humanizowanym łańcuchem lekkim
PT2847335T (pt) 2012-04-25 2018-09-28 Regeneron Pharma Alvejamento mediado por nuclease com vetores de alvejamento grandes
EP3561050B1 (en) 2013-02-20 2021-12-08 Regeneron Pharmaceuticals, Inc. Genetic modification of rats
HUE040575T2 (hu) * 2013-04-16 2019-03-28 Regeneron Pharma A patkány genom célzott módosítása
WO2014197934A1 (en) 2013-06-14 2014-12-18 The University Of Queensland Renal progenitor cells
US9546384B2 (en) 2013-12-11 2017-01-17 Regeneron Pharmaceuticals, Inc. Methods and compositions for the targeted modification of a mouse genome
KR102670874B1 (ko) 2014-03-04 2024-05-31 페이트 세러퓨틱스, 인코포레이티드 개선된 재프로그래밍 방법 및 세포 배양 플랫폼
CA2945263A1 (en) 2014-04-09 2015-10-15 Christopher Rudd Use of gsk-3 inhibitors or activators which modulate pd-1 or t-bet expression to modulate t cell immunity
JP6652334B2 (ja) 2014-05-31 2020-02-19 Ｊｃｒファーマ株式会社 ウリジンとｎ−アセチル−ｄ−マンノサミンとを含有する培地
LT3152312T (lt) 2014-06-06 2020-04-27 Regeneron Pharmaceuticals, Inc. Tikslinio lokuso modifikavimo būdai ir kompozicijos
EP3461885B1 (en) 2014-06-26 2021-10-20 Regeneron Pharmaceuticals, Inc. Methods and compositions for targeted genetic modifications and methods of use
HUE044907T2 (hu) 2014-11-21 2019-11-28 Regeneron Pharma Módszerek és készítmények célzott genetikai módosításhoz, párosított mutató RNS-ek használatával
NZ732895A (en) 2014-12-19 2022-05-27 Regeneron Pharma Methods and compositions for targeted genetic modification through single-step multiple targeting
SG11201707858TA (en) * 2015-03-30 2017-10-30 Ajinomoto Kk Human serum albumin-containing culture medium for growth of neural stem cells
EP3362570A4 (en) 2015-10-16 2019-03-20 Fate Therapeutics, Inc. PLATFORM FOR THE INDUCTION AND MAINTENANCE OF BASIC STATUS PLURIPOTENCE
MA45479A (fr) 2016-04-14 2019-02-20 Janssen Biotech Inc Différenciation de cellules souches pluripotentes en cellules de l'endoderme de l'intestin moyen
DK3519558T3 (da) 2016-09-28 2023-11-13 Organovo Inc Anvendelse af modificeret nyrevæv i assays
WO2019208787A1 (ja) * 2018-04-27 2019-10-31 株式会社カネカ 原始腸管細胞の製造方法
CN113316634A (zh) * 2018-11-21 2021-08-27 新加坡科技研究局 成熟的库普弗细胞的产生
CN111238897B (zh) * 2020-02-18 2023-03-28 上海市皮肤病医院 生物标本的处理方法与处理剂
JP2023532061A (ja) * 2020-07-02 2023-07-26 アクセルタ リミテッド 遅延胚由来の哺乳類家畜多能性幹細胞
EP4386082A4 (en) * 2021-08-10 2025-08-20 Kaneka Corp PROCESS FOR THE PRODUCTION OF PLURIPOTENT STEM CELLS
CN115927166A (zh) * 2022-12-06 2023-04-07 云南省第一人民医院 一种大鼠原始内胚层干细胞分离建系的方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004309421A1 (en) * 2003-12-23 2005-07-14 Viacyte, Inc. Definitive endoderm

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9308271D0 (en) 1993-04-21 1993-06-02 Univ Edinburgh Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method
AU7677894A (en) 1993-08-30 1995-03-22 Northwestern University Rat pluripotent embryonic stem cells and method of obtaining and using same
CA2267220A1 (en) 1996-10-11 1998-04-23 The Texas A & M University System Methods for the generation of primordial germ cells and transgenic animal species
US6214795B1 (en) 1996-11-12 2001-04-10 Praecis Pharmaceuticals, Inc. Peptide compounds useful for modulating FGF receptor activity
WO1998030679A1 (en) 1997-01-10 1998-07-16 Life Technologies, Inc. Embryonic stem cell serum replacement
WO1999027076A1 (en) 1997-11-25 1999-06-03 Arc Genomic Research Pluripotent embryonic stem cells and methods of obtaining them
GB9819912D0 (en) 1998-09-11 1998-11-04 Univ Edinburgh Propagation and/or derivation of embryonic stem cells
US7455983B2 (en) 2000-01-11 2008-11-25 Geron Corporation Medium for growing human embryonic stem cells
US20020045260A1 (en) 2000-10-17 2002-04-18 Shih-Chieh Hung Method of isolating mesenchymal stem cells
JP2002176973A (ja) 2000-12-14 2002-06-25 Shigeo Saito 哺乳動物胚性幹細胞とその樹立方法並びにその継代培養方法
AU2003210405A1 (en) 2002-03-05 2003-09-16 Artemis Pharmaceuticals Gmbh Inbred embryonic stem-cell derived mice
GB0210539D0 (en) 2002-05-08 2002-06-19 Univ Edinburgh Control of es cell self renewal and lineage specification, and medium therefor
US7338957B2 (en) 2003-08-28 2008-03-04 Irm Llc Compounds and compositions as protein kinase inhibitors
US8137966B2 (en) 2004-03-04 2012-03-20 Dainippon Sumitomo Pharma Co., Ltd. Rat embryonic stem cell
WO2005094830A1 (en) 2004-03-30 2005-10-13 Pfizer Products Inc. Combinations of signal transduction inhibitors
WO2005110438A2 (en) 2004-04-15 2005-11-24 Massachusetts Institute Of Technology Methods and products related to the intracellular delivery of polysaccharides
WO2006026473A2 (en) 2004-08-25 2006-03-09 University Of Georgia Research Foundation, Inc. METHODS AND COMPOSITIONS UTILIZING MYC AND GSK3ß TO MANIPULATE THE PLURIPOTENCY OF EMBRYONIC STEM CELLS
CN101238129A (zh) 2005-06-10 2008-08-06 Irm责任有限公司 维持胚胎干细胞多能性的化合物
JP2009517085A (ja) 2005-11-28 2009-04-30 チョンウェ ファーマ コーポレイション 培養における細胞の無血清増殖
EP1999249B8 (en) 2006-03-30 2012-02-15 The University Court Of The University of Edinburgh Culture medium containing kinase inhibitors. and uses thereof
WO2007113705A1 (en) * 2006-04-03 2007-10-11 Koninklijke Philips Electronics N. V. Determining tissue surrounding an object being inserted into a patient
EP2018167A4 (en) 2006-05-15 2010-07-14 Irm Llc COMPOSITIONS AND METHODS AS INHIBITORS OF FGF RECEPTOR KINASES

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004309421A1 (en) * 2003-12-23 2005-07-14 Viacyte, Inc. Definitive endoderm

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Ming Zhan，et al.Conservation and variation of gene regulation in embryonic stem cells assessed by comparative genomics.《Cell Biochemistry and Biophysics》.2005, *
Svetlana Vassilieva，et al.Establishment of SSEA-1- and Oct-4-Expressing Rat Embryonic Stem-like Cell Lines and Effects of Cytokines of the IL-6 Family on Clonal Growth.《Experimental Cell Research》.2000, *
XIANGPING LI,et al.Comparative analysis of development-related gene expression in mouse preimplantation embryos with different developmental potential.《MOLECULAR REPRODUCTION AND DEVELOPMENT》.2005, *

Also Published As

Publication number Publication date
AU2007280216A1 (en) 2008-02-07
WO2008015418A3 (en) 2008-04-10
GB0716426D0 (en) 2007-10-10
GB2451523A8 (en) 2009-02-18
JP2013176400A (ja) 2013-09-09
WO2008015418A2 (en) 2008-02-07
CN104531610A (zh) 2015-04-22
US20130333058A1 (en) 2013-12-12
JP2009545302A (ja) 2009-12-24
GB2451523A (en) 2009-02-04
AU2007280216B2 (en) 2012-12-20
GB0700479D0 (en) 2007-02-21
EP2049654A2 (en) 2009-04-22
CN101657535A (zh) 2010-02-24
GB0615327D0 (en) 2006-09-13
US20080066197A1 (en) 2008-03-13
GB2451523B (en) 2010-03-17
JP5456467B2 (ja) 2014-03-26
US8431395B2 (en) 2013-04-30

Similar Documents

Publication Publication Date Title
CN101657535B (zh) 源于大鼠及其它动物的多潜能细胞
Fang et al. Rabbit embryonic stem cell lines derived from fertilized, parthenogenetic or somatic cell nuclear transfer embryos
US11773368B2 (en) Culture method for differentiating primordial germ cells into functionally mature oocytes
US10561122B2 (en) Genetically modified rat derived from rat embryonic stem cell
Sofikitis et al. Efforts to create an artificial testis: culture systems of male germ cells under biochemical conditions resembling the seminiferous tubular biochemical environment
CN109486751B (zh) 用于无饲养细胞培养牛和猪的精原干细胞的方法
JP5807862B2 (ja) ラット胚性幹細胞を用いたキメララットの作製法
US20110044954A1 (en) Methods of producing germ-like cells and related therapies
Haraguchi et al. Establishment of self-renewing porcine embryonic stem cell-like cells by signal inhibition
Kanatsu-Shinohara et al. Anchorage-independent growth of mouse male germline stem cells in vitro
JPWO2018225802A1 (ja) 多能性幹細胞から生殖系列幹細胞様細胞への分化誘導方法
Williams et al. Oocyte-specific deletion of complex and hybrid N-glycans leads to defects in preovulatory follicle and cumulus mass development
Zhang et al. A novel chemically defined serum‐and feeder‐free medium for undifferentiated growth of porcine pluripotent stem cells
Cong et al. Derivation of putative porcine embryonic germ cells and analysis of their multi-lineage differentiation potential
JP2022114012A (ja) 多能性幹細胞から卵巣組織を分化させる培養技術
AU2013201718B2 (en) Pluripotent cells from rat and other species
Oback et al. Pluripotent stem cells in livestock
Kubota et al. Transplantation and culture of spermatogonial stem cells
Heo et al. Production of somatic chimera chicks by injection of bone marrow cells into recipient blastoderms
Beteramia Pluripotent adult stem cells from the mouse testis
Yu et al. Isolation and characterization of parthenogenetic embryonic stem (pES) cells containing genetic background of the Kunming mouse strain
Choi et al. Promoted expression of Igf-1, Dnmt3a and Oct-4 in the parthenogenetic murine blastocysts developed in an oil-free microtube culture system may support stem cell generation
Angeles et al. Germ Cell Differentiation
Davies et al. Embryonic stem cells and the capture of pluripotency
Panula Modeling human germ cell development with pluripotent stem cells and characterizing the putative oogonial stem cells

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20160302

Termination date: 20160801

CF01 Termination of patent right due to non-payment of annual fee